Therapeutic area intelligence for GnRH Antagonist with 3 indexed intelligence signals across regulatory, clinical, competitive, and market developments.

Signals: 3
Catalysts: 0
Companies: 1

Companies

Epic Pharma →

Assets

FDA →

Humanwell →

Recent signals(3)

RegulatoryJuly 31, 2026

FDA Grants Approval for Cetrorelix Acetate Application ANDA218740

The FDA has granted approval for the ANDA218740 application for Cetrorelix Acetate submitted by Humanwell.

RegulatoryJuly 8, 2026

FDA Grants Approval for Cetrorelix Acetate by Epic Pharma

The FDA has granted approval for the ANDA218740 application for Cetrorelix Acetate submitted by Epic Pharma.

RegulatoryJune 23, 2026

FDA Grants AP Status for SUN PHARM's Ganirelix Acetate Supplement

The FDA has granted an Abbreviated New Drug Application (ANDA) approval status for SUN PHARM's supplement of Ganirelix Acetate.

Upcoming catalysts

No catalysts indexed for this entity yet.

Indications

No related entities indexed yet.

Newsletter

Get signals before the market moves

Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.

No paywall. No spam. Unsubscribe anytime.